Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool

Author:

Margiana Ria1234ORCID

Affiliation:

1. Department of Anatomy, Faculty of Medicine Universitas Indonesia Jakarta Indonesia

2. Master's Programme Biomedical Sciences, Faculty of Medicine Universitas Indonesia Jakarta Indonesia

3. Andrology Program, Faculty of Medicine Universitas Airlangga Surabaya Indonesia

4. Dr. Soetomo General Academic Hospital Surabaya Indonesia

Abstract

AbstractPreeclampsia (PE) is a major gestational disorder that causes both long‐ and short‐term damage to both the mother and the fetus. Endometrium decidualization and the formation of the placenta are orchestrated by mesenchymal stem cells (MSCs). MSCs obtained from patients with PE exhibit an elevated rate of aging and apoptosis, which impairs the interplay between MSCs and endothelium, trophoblast, and immune cells in the placenta, accelerating the onset of PE. Preclinical and clinical evidence imply that the MSC‐based therapy approach for PE is prospective. Importantly, as a novel cell‐free approach, MSC‐derived exosomes can improve symptoms and maternal–fetal survival in PE models by raising cell metabolism, encouraging angiogenesis balance, and regulating immune responses. Even following allogeneic administration, the likelihood of immune rejection is very limited as a result of the small quantity of exosome membrane‐bound proteins. Furthermore, because exosomes do not expand, developing tumors is not probable. As a result, MSC‐derived exosomes show superiority over MSCs in terms of safety. For the first time, we outline the properties of MSC‐exosomes and highlight their functions and potential as a new paradigm for PE therapy in this review.

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,General Medicine,Biochemistry

Reference155 articles.

1. Preeclampsia;Ramos JGL;RBGO Gynecol Obstetr,2017

2. Preeclampsia

3. Medicover Genetics. Test N‐IP sequencing WE kits TI. Preeclampsia–diagnosis symptoms genetics causes and treatment. February 1 2023.

4. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention

5. Pre‐eclampsia and long‐term health outcomes for mother and infant: an umbrella review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3